Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2012

01-09-2012 | Epidemiology

Mammographic density and breast cancer risk in White and African American Women

Authors: Hilda Razzaghi, Melissa A. Troester, Gretchen L. Gierach, Andrew F. Olshan, Bonnie C. Yankaskas, Robert C. Millikan

Published in: Breast Cancer Research and Treatment | Issue 2/2012

Login to get access

Abstract

Mammographic density is a strong risk factor for breast cancer, but limited data are available in African American (AA) women. We examined the association between mammographic density and breast cancer risk in AA and white women. Cases (n = 491) and controls (n = 528) were from the Carolina Breast Cancer Study (CBCS) who also had mammograms recorded in the Carolina Mammography Registry (CMR). Mammographic density was reported to CMR using Breast Imaging Reporting and Data System (BI-RADS) categories. Increasing mammographic density was associated with increased breast cancer risk among all women. After adjusting for potential confounders, a monotonically increasing risk of breast cancer was observed between the highest versus the lowest BI-RADS density categories [OR = 2.45, (95 % confidence interval: 0.99, 6.09)]. The association was stronger in whites, with ~40 % higher risk among those with extremely dense breasts compared to those with scattered fibroglandular densities [1.39, (0.75, 2.55)]. In AA women, the same comparison suggested lower risk [0.75, (0.30, 1.91)]. Because age, obesity, and exogenous hormones have strong associations with breast cancer risk, mammographic density, and race in the CBCS, effect measure modification by these factors was considered. Consistent with previous literature, density-associated risk was greatest among those with BMI > 30 and current hormone users (P value = 0.02 and 0.01, respectively). In the CBCS, mammographic density is associated with increased breast cancer risk, with some suggestion of effect measure modification by race, although results were not statistically significant. However, exposures such as BMI and hormone therapy may be important modifiers of this association and merit further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolfe JN (1976) Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 126:1130–1137PubMed Wolfe JN (1976) Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 126:1130–1137PubMed
2.
go back to reference Wolfe JN (1976) Breast parenchymal patterns and their changes with age. Radiology 121:545–552PubMed Wolfe JN (1976) Breast parenchymal patterns and their changes with age. Radiology 121:545–552PubMed
3.
go back to reference Tabar L, Dean P (1982) Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 247:185–189PubMedCrossRef Tabar L, Dean P (1982) Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA 247:185–189PubMedCrossRef
4.
go back to reference D’Orsi C, Bassett L, Berg W et al (2003) Breast imaging reporting and data system: ACR BI-RADS-mammography, 4th edn. American College of Radiology, Reston, VA D’Orsi C, Bassett L, Berg W et al (2003) Breast imaging reporting and data system: ACR BI-RADS-mammography, 4th edn. American College of Radiology, Reston, VA
5.
go back to reference McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169PubMedCrossRef McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169PubMedCrossRef
6.
go back to reference Warner E, Lockwood G, Math M, Tritchler D, Boyd NF (1992) The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prevent 16:67–72PubMed Warner E, Lockwood G, Math M, Tritchler D, Boyd NF (1992) The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prevent 16:67–72PubMed
7.
go back to reference Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA (2007) Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 16:43–49PubMedCrossRef Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA (2007) Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 16:43–49PubMedCrossRef
8.
go back to reference Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670–675PubMedCrossRef Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ (1995) Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670–675PubMedCrossRef
9.
go back to reference Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K (2003) Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 95:556–558PubMedCrossRef Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K (2003) Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 95:556–558PubMedCrossRef
10.
go back to reference Boyd NF, Lockwood GA, Byng JW (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144PubMed Boyd NF, Lockwood GA, Byng JW (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144PubMed
11.
go back to reference Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332–338PubMed Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC (2003) Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332–338PubMed
12.
go back to reference Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN (2005) Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol 162:743–752PubMedCrossRef Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN (2005) Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol 162:743–752PubMedCrossRef
13.
go back to reference Brisson J, Merletti F, Sadowsky NL, Twaddle JA, Morrison AS, Cole P (1982) Mammographic features of the breast and breast cancer risk. Am J Epidemiol 115:428–437PubMed Brisson J, Merletti F, Sadowsky NL, Twaddle JA, Morrison AS, Cole P (1982) Mammographic features of the breast and breast cancer risk. Am J Epidemiol 115:428–437PubMed
14.
go back to reference Chen Z, Wu A, Gauderman WJ (2004) Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 159:140–147PubMedCrossRef Chen Z, Wu A, Gauderman WJ (2004) Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 159:140–147PubMedCrossRef
15.
go back to reference Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M et al (2007) Mammographic density in a multiethnic cohort. Menopause 14:891–899PubMedCrossRef Habel LA, Capra AM, Oestreicher N, Greendale GA, Cauley JA, Bromberger J, Crandall CJ, Gold EB, Modugno F, Salane M et al (2007) Mammographic density in a multiethnic cohort. Menopause 14:891–899PubMedCrossRef
16.
go back to reference El-Bastawissi AY, White E, Mandelson MT, Taplin S (2001) Variation in mammographic breast density by race. Ann Epidemiol 11:257–263PubMedCrossRef El-Bastawissi AY, White E, Mandelson MT, Taplin S (2001) Variation in mammographic breast density by race. Ann Epidemiol 11:257–263PubMedCrossRef
17.
go back to reference Tehranifar P, Reynolds D, Flom J, Fulton L, Liao Y, Kudadjie-Gyamfi E, Terry M (2011) Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women. Cancer Causes Control 22:599–610PubMedCrossRef Tehranifar P, Reynolds D, Flom J, Fulton L, Liao Y, Kudadjie-Gyamfi E, Terry M (2011) Reproductive and menstrual factors and mammographic density in African American, Caribbean, and white women. Cancer Causes Control 22:599–610PubMedCrossRef
18.
go back to reference del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS (2007) Mammographic breast density and race. AJR Am J Roentgenol 188:1147–1150PubMedCrossRef del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS (2007) Mammographic breast density and race. AJR Am J Roentgenol 188:1147–1150PubMedCrossRef
19.
go back to reference del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J (2003) Racial differences in mammographic breast density. Cancer 98:590–596PubMedCrossRef del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J (2003) Racial differences in mammographic breast density. Cancer 98:590–596PubMedCrossRef
20.
go back to reference Wolfe JN, Saftlas AF, Salane M (1987) Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 148:1087–1092PubMed Wolfe JN, Saftlas AF, Salane M (1987) Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol 148:1087–1092PubMed
21.
go back to reference O’Brien KM, Cole SR, Tse C-K, Perou CM, Carey LA, Foulkes WD, Dressler LG, Geradts J, Millikan RC (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16:6100–6110PubMedCrossRef O’Brien KM, Cole SR, Tse C-K, Perou CM, Carey LA, Foulkes WD, Dressler LG, Geradts J, Millikan RC (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 16:6100–6110PubMedCrossRef
22.
go back to reference Millikan R, Newman B, Tse C-K, Moorman P, Conway K, Smith L, Labbok M, Geradts J, Bensen J, Jackson S et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRef Millikan R, Newman B, Tse C-K, Moorman P, Conway K, Smith L, Labbok M, Geradts J, Bensen J, Jackson S et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123–139PubMedCrossRef
23.
go back to reference Hall IJ, Moorman PG, Millikan RC, Newman B (2005) Comparative analysis of breast cancer risk factors among African-American Women and White Women. Am J Epidemiol 161:40–51PubMedCrossRef Hall IJ, Moorman PG, Millikan RC, Newman B (2005) Comparative analysis of breast cancer risk factors among African-American Women and White Women. Am J Epidemiol 161:40–51PubMedCrossRef
24.
go back to reference Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE, Liu ET (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35:51–60PubMedCrossRef Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE, Liu ET (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35:51–60PubMedCrossRef
25.
go back to reference Weinberg CR, Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol 134:421–432PubMed Weinberg CR, Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol 134:421–432PubMed
26.
go back to reference Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y, Geradts J, Iacocca M, Cowan D, Conway K, Dressler L (2003) HER2 codon 655 polymorphism and risk of breast cancer in African Americans and Whites. Breast Cancer Res Treat 79:355–364PubMedCrossRef Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y, Geradts J, Iacocca M, Cowan D, Conway K, Dressler L (2003) HER2 codon 655 polymorphism and risk of breast cancer in African Americans and Whites. Breast Cancer Res Treat 79:355–364PubMedCrossRef
27.
go back to reference Moorman PG, Kuwabara H, Millikan RC, Newman B (2000) Menopausal hormones and breast cancer in a biracial population. Am J Public Health 90:966–971PubMedCrossRef Moorman PG, Kuwabara H, Millikan RC, Newman B (2000) Menopausal hormones and breast cancer in a biracial population. Am J Public Health 90:966–971PubMedCrossRef
28.
go back to reference Yankaskas B, Jones M, Aldrich T (1996) The Carolina Mammography Registry: a population-based mammography and cancer surveillance project. J Regist Manag 23:173–178 Yankaskas B, Jones M, Aldrich T (1996) The Carolina Mammography Registry: a population-based mammography and cancer surveillance project. J Regist Manag 23:173–178
29.
go back to reference Gomatam S, Carter R, Ariet M, Mitchell G (2002) An empirical comparison of record linkage procedures. Stat Med 21:1485–1496PubMedCrossRef Gomatam S, Carter R, Ariet M, Mitchell G (2002) An empirical comparison of record linkage procedures. Stat Med 21:1485–1496PubMedCrossRef
30.
31.
go back to reference Quantin C, Binquet C, Bourquard K, Pattisina R, Gouyon-Cornet B, Ferdynus C, Gouyon J-B, Allaert FA (2004) Which are the best identifiers for record linkage? Med Inf Internet Med 29:221–227CrossRef Quantin C, Binquet C, Bourquard K, Pattisina R, Gouyon-Cornet B, Ferdynus C, Gouyon J-B, Allaert FA (2004) Which are the best identifiers for record linkage? Med Inf Internet Med 29:221–227CrossRef
32.
go back to reference Vachon C, van Gils C, Sellers T, Ghosh K, Pruthi S, Brandt K, Pankratz VS (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9:217PubMedCrossRef Vachon C, van Gils C, Sellers T, Ghosh K, Pruthi S, Brandt K, Pankratz VS (2007) Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9:217PubMedCrossRef
33.
go back to reference Yaffe M, Boyd N, Byng J, Jong R, Fishell E, Lockwood G, Little L, Tritchler D (1998) Breast cancer risk and measured mammographic density. Eur J Cancer Prev Suppl 1:S47–S55CrossRef Yaffe M, Boyd N, Byng J, Jong R, Fishell E, Lockwood G, Little L, Tritchler D (1998) Breast cancer risk and measured mammographic density. Eur J Cancer Prev Suppl 1:S47–S55CrossRef
34.
go back to reference Kerlikowske K, Grady D, Barclay J, Frankel SD, Ominsky SH, Sickles EA, Ernster V (1998) Variability and accuracy in mammographic interpretation using the American college of radiology breast imaging reporting and data system. J Natl Cancer Inst 90:1801–1809PubMedCrossRef Kerlikowske K, Grady D, Barclay J, Frankel SD, Ominsky SH, Sickles EA, Ernster V (1998) Variability and accuracy in mammographic interpretation using the American college of radiology breast imaging reporting and data system. J Natl Cancer Inst 90:1801–1809PubMedCrossRef
35.
go back to reference Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629PubMedCrossRef Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629PubMedCrossRef
36.
go back to reference Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG (1995) A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 6:431–438PubMedCrossRef Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG (1995) A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control 6:431–438PubMedCrossRef
37.
go back to reference Thomas DB, Carter RA, Bush WH, Ray RM, Stanford JL, Lehman CD, Daling JR, Malone K, Davis S (2002) Risk of subsequent breast cancer in relation to characteristics of screening mammograms from women less than 50 years of age. Cancer Epidemiol Biomark Prev 11:565–571 Thomas DB, Carter RA, Bush WH, Ray RM, Stanford JL, Lehman CD, Daling JR, Malone K, Davis S (2002) Risk of subsequent breast cancer in relation to characteristics of screening mammograms from women less than 50 years of age. Cancer Epidemiol Biomark Prev 11:565–571
38.
go back to reference Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621–628PubMedCrossRef Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621–628PubMedCrossRef
39.
go back to reference Mandelson M, Oestreicher N, Porter P, White D, Finder C, Taplin S, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087PubMedCrossRef Mandelson M, Oestreicher N, Porter P, White D, Finder C, Taplin S, White E (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087PubMedCrossRef
40.
go back to reference Greenland S, Pearl J, Robins J (1999) Causal diagrams for epidemiologic research. Epidemiology 10:37–48PubMedCrossRef Greenland S, Pearl J, Robins J (1999) Causal diagrams for epidemiologic research. Epidemiology 10:37–48PubMedCrossRef
41.
go back to reference Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K (2004) Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomark Prev 13:2090–2095 Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K (2004) Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomark Prev 13:2090–2095
42.
go back to reference El-Bastawissi AY, White E, Mandelson MT, Taplin SH (2000) Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 11:955–963PubMedCrossRef El-Bastawissi AY, White E, Mandelson MT, Taplin SH (2000) Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 11:955–963PubMedCrossRef
43.
go back to reference Sung J, Song Y-M, Stone J, Lee K, Kim S-Y (2010) Association of body size measurements and mammographic density in Korean Women: the Healthy Twin Study. Cancer Epidemiol Biomark Prev 19:1523–1531CrossRef Sung J, Song Y-M, Stone J, Lee K, Kim S-Y (2010) Association of body size measurements and mammographic density in Korean Women: the Healthy Twin Study. Cancer Epidemiol Biomark Prev 19:1523–1531CrossRef
44.
go back to reference Conroy SM, Woolcott CG, Koga KR, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I, Maskarinec G (2011) Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies. Int J Cancer 130(8):1915–1924PubMedCrossRef Conroy SM, Woolcott CG, Koga KR, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I, Maskarinec G (2011) Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies. Int J Cancer 130(8):1915–1924PubMedCrossRef
45.
go back to reference Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30–37PubMedCrossRef Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G (2003) Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 95:30–37PubMedCrossRef
46.
go back to reference Harvey J, Scheurer C, Kawakami FT, Quebe-Fehling E, de Palacios PI, Ragavan VV (2005) Hormone replacement therapy and breast density changes. Climacteric 8:185–192PubMedCrossRef Harvey J, Scheurer C, Kawakami FT, Quebe-Fehling E, de Palacios PI, Ragavan VV (2005) Hormone replacement therapy and breast density changes. Climacteric 8:185–192PubMedCrossRef
47.
go back to reference Van Duijnhoven FJB, Peeters PHM, Warren RML, Bingham SA, van Noord PAH, Monninkhof EM, Grobbee DE, van Gils CH (2007) Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 25:1323–1328PubMedCrossRef Van Duijnhoven FJB, Peeters PHM, Warren RML, Bingham SA, van Noord PAH, Monninkhof EM, Grobbee DE, van Gils CH (2007) Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol 25:1323–1328PubMedCrossRef
48.
go back to reference Stomper PC, Van Voorhis BJ, Ravnika VA, Meyer JE (1990) Mammographic changes associated with postmenopausal hormone replacement therapy; a longitudinal study. Radiology 174:487–490PubMed Stomper PC, Van Voorhis BJ, Ravnika VA, Meyer JE (1990) Mammographic changes associated with postmenopausal hormone replacement therapy; a longitudinal study. Radiology 174:487–490PubMed
49.
go back to reference Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171–176PubMedCrossRef Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285:171–176PubMedCrossRef
50.
go back to reference Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333CrossRef Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333CrossRef
51.
go back to reference Kerlikowske K, Cook AJ, Buist DSM, Cummings SR, Vachon C, Vacek P, Miglioretti DL (2010) Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 28:3830–3837PubMedCrossRef Kerlikowske K, Cook AJ, Buist DSM, Cummings SR, Vachon C, Vacek P, Miglioretti DL (2010) Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol 28:3830–3837PubMedCrossRef
52.
go back to reference Ciatto S, Houssami N, Apruzzese A, Bassetti E, Brancato B, Carozzi F, Catarzi S, Lamberini MP, Marcelli G, Pellizzoni R, Pesce B, Risso G, Russo F, Scorsolini A (2005) Categorizing breast mammographic density intra- and interobserver reproducibility of BI-RADS density categories. The Breast 14:269–275PubMedCrossRef Ciatto S, Houssami N, Apruzzese A, Bassetti E, Brancato B, Carozzi F, Catarzi S, Lamberini MP, Marcelli G, Pellizzoni R, Pesce B, Risso G, Russo F, Scorsolini A (2005) Categorizing breast mammographic density intra- and interobserver reproducibility of BI-RADS density categories. The Breast 14:269–275PubMedCrossRef
Metadata
Title
Mammographic density and breast cancer risk in White and African American Women
Authors
Hilda Razzaghi
Melissa A. Troester
Gretchen L. Gierach
Andrew F. Olshan
Bonnie C. Yankaskas
Robert C. Millikan
Publication date
01-09-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2185-3

Other articles of this Issue 2/2012

Breast Cancer Research and Treatment 2/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine